Biote Corporation (BTMD) Long-Term Debt to Capital Coefficient

Symbol and logo of brand biote Corp. (BTMD)

biote Corp. (BTMD) leads the personalized hormone correction segment, leveraging a proprietary subcutaneous implant method and a medical professional training system. Market capitalization is based on the sale of bioidentical pellets for individuals experiencing age-related changes. Meanwhile, R&D development is focused on applied software and the refinement of protocols, as confirmed by this price chart. The current metric stands at 0.00.

BTMD biote Corp: Long-Term Debt to Capital in the range 04/28/2023 - 10/30/2026
Finished products of biote Corp

This metric measures the ratio of liabilities with a maturity exceeding one year to total equity, determining the issuer's degree of financial autonomy. The current long-term credit leverage at 0.00 reflects biote Corp. (BTMD) dependence on borrowed funds to scale its hormone therapy network and expand its nutraceutical product line to diversify revenue.

Analysis of competing companies

HCA (HCA Holdings) - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Tenet (THC)|FMS (Fresenius Medical) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital SOLV (Solventum Corporation)|encompasshealth.com (EHC) - Long-Term Liabilities to Capital|Universal Health Services Corp - Long-Term Debt to Capital|DVA - Long-Term Debt to Capital|RDNT (RadNet Corp) - Long-Term Debt to Equity Ratio|OPCH: Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Surgery Partners, Inc.|Long-Term Debt to Equity Ratio premierinc.com (PINC)|Long-Term Debt to Capital EYE|PGNY - Long-Term Liabilities to Capital|Long-Term Debt to Equity Ardent Health Partners Inc ARDT|SEM: Long-Term Debt to Capital Ratio|ASTH: Long-Term Debt to Equity Ratio|Pediatrix Medical Group, Inc. - Long-Term Loans to Capital Ratio|USPH: Long-Term Debt to Capital|PNTG (Pennant Group) - Long-Term Debt to Equity|ORGO (Organogenesis Inc.) - Long-Term Debt to Capital|Nutex Health Hospitals (NUTX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Auna SA (AUNA)|SBC - Long-Term Liabilities to Capital|Evolus - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio CYH (CHS)|Beauty Health - Long-Term Debt to Capital|Long-Term Liabilities to Capital MediWound Ltd.|JYNT (The Joint Corp.) - Long-Term Debt to Equity Ratio|docgo.com - Long-Term Debt to Capital Coefficient|PIII (P3 Health Partners, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Gain Therapeutics Inc. (GANX)|Long-Term Debt to Equity EUDA Health (EUDA)|BMGL - Long-Term Liabilities to Capital|Long-Term Debt to Equity CollPlant Biotechnologies Ltd. CLGN|Long-Term Debt to Capital Coefficient CUPR|CCM - Long-Term Debt to Equity|Long-Term Liabilities to Equity AMS|MRM (MEDIROM Healthcare Group Inc) - Long-Term Debt to Equity Ratio|ALBT - Ratio of Long-Term Indebtedness to Capital|DHAI (DIH Holding US, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Equity XAGE|Long-Term Debt to Equity Ratio NIVF (NewGenIvf)|Long-Term Loans to Capital Ratio ATIP|Long-Term Debt to Equity CareMax Medical Group CMAX|KDLY - Long-Term Debt to Equity Ratio|ModivCare Inc. - Long-Term Debt to Capital|NVOS (novointegrated.com) - Long-Term Debt to Capital Ratio|SSY (sunlinkhealth.com) - Long-Term Debt to Equity Ratio|BACK: Long-Term Loans to Capital Ratio